These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 7943174)
1. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Shih IM; Elder DE; Hsu MY; Herlyn M Am J Pathol; 1994 Oct; 145(4):837-45. PubMed ID: 7943174 [TBL] [Abstract][Full Text] [Related]
2. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790 [TBL] [Abstract][Full Text] [Related]
3. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Shih IM; Speicher D; Hsu MY; Levine E; Herlyn M Cancer Res; 1997 Sep; 57(17):3835-40. PubMed ID: 9288796 [TBL] [Abstract][Full Text] [Related]
4. Keratinocytes express the CD146 (Muc18/S-endo) antigen in tissue culture and during inflammatory skin diseases. Weninger W; Rendl M; Mildner M; Mayer C; Ban J; Geusau A; Bayer G; Tanew A; Majdic O; Tschachler E J Invest Dermatol; 2000 Aug; 115(2):219-24. PubMed ID: 10951239 [TBL] [Abstract][Full Text] [Related]
6. The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Shih LM; Hsu MY; Palazzo JP; Herlyn M Am J Pathol; 1997 Sep; 151(3):745-51. PubMed ID: 9284823 [TBL] [Abstract][Full Text] [Related]
7. Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM). Schön M; Kähne T; Gollnick H; Schön MP J Invest Dermatol; 2005 Aug; 125(2):353-63. PubMed ID: 16098047 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen. Kraus A; Masat L; Johnson JP Melanoma Res; 1997 Aug; 7 Suppl 2():S75-81. PubMed ID: 9578420 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Hsu MY; Meier FE; Nesbit M; Hsu JY; Van Belle P; Elder DE; Herlyn M Am J Pathol; 2000 May; 156(5):1515-25. PubMed ID: 10793063 [TBL] [Abstract][Full Text] [Related]
10. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma. Meier F; Caroli U; Satyamoorthy K; Schittek B; Bauer J; Berking C; Möller H; Maczey E; Rassner G; Herlyn M; Garbe C Exp Dermatol; 2003 Jun; 12(3):296-306. PubMed ID: 12823444 [TBL] [Abstract][Full Text] [Related]
12. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768 [TBL] [Abstract][Full Text] [Related]
13. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM. Rummel MM; Sers C; Johnson JP Cancer Res; 1996 May; 56(9):2218-23. PubMed ID: 8616875 [TBL] [Abstract][Full Text] [Related]
14. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718 [TBL] [Abstract][Full Text] [Related]
15. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Sers C; Riethmüller G; Johnson JP Cancer Res; 1994 Nov; 54(21):5689-94. PubMed ID: 7923217 [TBL] [Abstract][Full Text] [Related]
16. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Lehmann JM; Riethmüller G; Johnson JP Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9891-5. PubMed ID: 2602381 [TBL] [Abstract][Full Text] [Related]
17. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Shih IM; Nesbit M; Herlyn M; Kurman RJ Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208 [TBL] [Abstract][Full Text] [Related]
18. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling. Li G; Fukunaga M; Herlyn M Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432 [TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of carcinoembryonic antigen by a melanoma cell leads to changes in the transcription of two additional cell adhesion molecules. Grimm T; Johnson JP Cancer Res; 1995 Aug; 55(15):3254-7. PubMed ID: 7614458 [TBL] [Abstract][Full Text] [Related]
20. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]